| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |